Table 1.
Demographic and clinical characteristics of the patients.
| Variables | cAMR group (n = 28) | SGF group (n = 20) | P value |
|---|---|---|---|
| Age (years) | 41.32 (14.62) | 39.15 (10.17) | 0.57 |
| 40 [30.00, 51.50] | 39 [34.00, 41.00] | ||
| Sex (women) | 9 (32.14) | 6 (30.00) | 0.88 |
| Post-TX time | 59.71 (64.39) | 62.80 (35.92) | 0.37 |
| 39.00 [2.25, 84.00] | 60.00 [36.00, 84.00] | ||
| Weight (kg) | 71.42 (17.24) | 73.60 (9.79) | 0.62 |
| 72.50 [57.75, 83.25] | 74.50 [73.00, 81.50] | ||
| FBS (mg/dl) | 121.35 (81.24) | 115.45 (50.67) | 0.81 |
| 97.00 [86.50, 114.50] | 100.50 [94.00, 116.00] | ||
| Triglycerides (mg/dl) | 120.00 (56.72) | 131.70 (73.11) | 0.53 |
| 110.50 [90.00,145.00] | 131.50 [95.00, 145.50] | ||
| Cholesterol (mg/dl) | 151.17 (30.12) | 173.05 (51.29) | 0.07 |
| 150.00 [131.50, 165.50] | 173.00 [151.50, 186.50] | ||
| HDL (mg/dl) | 47.54 (16.94) | 47.00 (17.25) | 0.96 |
| 47.00 [36.00, 57.50] | 47.00 [41.00, 55.50] | ||
| LDL (mg/dl) | 82.96 (26.16) | 87.10 (40.59) | 0.66 |
| 84.00 [70.50, 102.00] | 87.00 [62.00, 98.00] | ||
| Sodium (Meq/I) | 136.89 (6.03) | 140.63 (3.16) | 0.02 |
| 136.50 [134.50, 140.50] | 141.00 [139.00, 142.00] | ||
| Potassium (Meq/I) | 4.40 (0.84) | 4.32 (1.18) | 0.79 |
| 4.35 [4.00, 4.90] | 4.19 [3.80, 4.30] | ||
| Phosphorus (mg/dl) | 5.11 (1.69) | 3.69 (0.90) | 0.001 |
| 4.90 [3.90, 5.80] | 3.70 [3.15, 3.84] | ||
| Calcium (mg/dl) | 8.40 (0.87) | 9.27 (0.31) | <0.001 |
| 8.55 [7.75, 9.00] | 9.30 [9.15, 9.45] | ||
| Uric acid (mg/dl) | 7.69 (2.61) | 5.58 (1.51) | 0.002 |
| 7.35 [6.15, 9.15] | 5.50 [4.95, 5.85] | ||
| Urea (mg/dl) | 83.75 (42.39) | 41.16 (16.93) | <0.001 |
| 89.50 [53.00, 108.50] | 39.00 [30.00, 48.00] | ||
| BUN (mg/dl) | 37.68 (1.88) | 25.70 (14.41) | 0.02 |
| 41.80 [23.65, 48.48] | 23.28 [25.96, 28.60] | ||
| eGFR (ml/min/1.73 m2) | 21.35 (17.06) | 63.17 (16.13) | <0.001 |
| 13.81 [10.34, 29.36] | 63.53 [58.85, 71.97] | ||
| Creatinine (mg/dl) | 4.41 (2.31) | 1.31 (0.66) | <0.001 |
| 4.10 [2.55, 6.26] | 1.18 [1.07, 1.30] | ||
| WBC (∗103/μl) | 7.44 (3.41) | 6.66 (1.20) | 0.33 |
| 6.30 [5.20, 9.20] | 6.60 [5.70, 7.50] | ||
| Platelet (∗103/μl) | 185.03 (86.59) | 218.20 (60.23) | 0.15 |
| 180.50 [125.00, 229.50] | 218.00 [206.00, 263.00] | ||
| Lymphocyte (%) | 20.24 (8.34) | 25.00 (3.99) | 0.02 |
| 21.41 [14.00, 26.00] | 25.00 [25.00, 25.00] | ||
| Hemoglobin (g/dl) | 9.98 (2.14) | 13.48 (2.97) | <0.001 |
| 9.75 [8.15, 11.47] | 13.85 [13.50, 15.30] | ||
| Hematocrit (%) | 32.02 (7.23) | 40.27 (7.42) | <0.001 |
| 30.50 [27.20, 34.75] | 40.20 [38.55, 46.25] |
Scale and nominal variables were depicted as mean (SD) and median [Q1; Q3] and number (percent), respectively. The Mann–Whitney U test was used for the evaluation of intergroup differences. Abbreviations: cAMR: chronic antibody-mediated rejection; SGF: stable graft function; FBS: fasting blood sugar; HDL: high-density lipoprotein; LDL: low-density lipoprotein; BUN: blood urine nitrogen; eGFR: estimated glomerular filtration rate; WBC: white blood cell.